Genmab's Outlook Beyond Darzalex's Patent Cliff

Editor's note: Seeking Alpha is proud to welcome Solomon Oshabaheebwa as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.I am an independent investor and analyst with a background in Biomedical Engineering. Currently pursuing a PhD in the field, I leverage my research skills and biotech expertise to critically assess publicly traded companies, focusing o ...